المؤلفون: Neppelenbroek SIM; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Geurts YM; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Aleman BMP; Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Lugtenburg PJ; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands., Rademakers SE; Department of Radiation Oncology, Leiden University Medical Center, Leiden, the Netherlands., de Weijer RJ; Department of Hematology, University Medical Center Utrecht, Utrecht, the Netherlands., Schippers MGA; Department of Radiation Oncology, Instituut Verbeeten, Tilburg, the Netherlands., Ta BDP; Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, Maastricht, the Netherlands., Plattel WJ; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Zijlstra JM; Department of Hematology, Amsterdam UMC, Location Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, the Netherlands., van der Maazen RWM; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Nijziel MR; Catharina Cancer Institute, Department of Hemato-Oncology, Catharina Hospital, Eindhoven, the Netherlands., Ong F; Department of Radiotherapy, Medisch Spectrum Twente, Enschede, the Netherlands., Schimmel EC; Department of Radiotherapy, Radiotherapiegroep, Arnhem, the Netherlands., Posthuma EFM; Department of Internal Medicine, Reinier de Graaf Hospital, Delft, the Netherlands., Kersten MJ; Department of Hematology, Amsterdam University Medical Centers, Location University of Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands., Böhmer LH; Department of Hematology, Haga Teaching Hospital, Den Haag, the Netherlands., Muller K; Department of Radiotherapy, Radiotherapiegroep, Deventer, the Netherlands., Koene HR; Department of Hematology, St Antonius Hospital, Nieuwegein, the Netherlands., Te Boome LCJ; Department of Hematology, Haaglanden Medical Center, Den Haag, the Netherlands., Bilgin YM; Department of Internal Medicine, Admiraal De Ruyter Hospital, Goes, the Netherlands., de Jongh E; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands., Janus CPM; Department of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands., van Leeuwen FE; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Schaapveld M; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Jun 01; Vol. 42 (16), pp. 1903-1913. Date of Electronic Publication: 2024 Feb 15.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Hodgkin Disease*/epidemiology , Hodgkin Disease*/drug therapy , Doxorubicin*/adverse effects , Doxorubicin*/administration & dosage , Breast Neoplasms*/epidemiology , Breast Neoplasms*/drug therapy , Cancer Survivors*/statistics & numerical data, Humans ; Female ; Adolescent ; Adult ; Middle Aged ; Young Adult ; Antibiotics, Antineoplastic/adverse effects ; Incidence ; Netherlands/epidemiology ; Risk Factors

المؤلفون: Geurts YM; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam., Neppelenbroek SIM; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam., Aleman BMP; Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam., Janus CPM; Department of Radiotherapy, Erasmus Medical Centre, Rotterdam., Krol ADG; Department of Radiation Oncology, Leiden University Medical Centre, Leiden., van Spronsen DJ; Department of Hematology, Radboud University Medical Centre, Nijmegen., Plattel WJ; Department of Hematology, University Medical Centre Groningen, Groningen., Roesink JM; Department of Radiotherapy, University Medical Centre Utrecht, Utrecht., Verschueren KMS; Department of Radiation Oncology, Institute Verbeeten, Tilburg., Zijlstra JM; Department of Hematology, Amsterdam UMC location Vrije Universiteit, Cancer Centre Amsterdam, Amsterdam., Koene HR; Department of Internal Medicine, St. Antonius Hospital, Nieuwegein., Nijziel MR; Catharina Cancer Institute, Department of Hemato-Oncology, Catharina Hospital, Eindhoven., Schimmel EC; Radiotherapiegroep, Arnhem., de Jongh E; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht., Ong F; Department of Radiotherapy, Medisch Spectrum Twente, Enschede., Te Boome LCJ; Department of Hematology, Haaglanden Medical Centre, The Hague., van Rijn RS; Department of Internal Medicine, Medical Centre Leeuwarden, Leeuwarden., Böhmer LH; Department of Hematology, Haga Teaching Hospital, The Hague., Ta BDP; Department of Radiation Oncology (MAASTRO), GROW School for Oncology, Maastricht University Medical Centre+, Maastricht., Visser HPJ; Department of Hematology, Noordwest Ziekenhuisgroep Alkmaar, Alkmaar., Posthuma EFM; Department of Internal Medicine, Reinier de Graaf Hospital, Delft., Bilgin YM; Department of Internal Medicine, ADRZ, Goes., Muller K; Radiotherapiegroep, Deventer., van Kampen D; Zuidwest Radiotherapeutisch Instituut, Vlissingen., So-Osman C; Department of Hematology, Erasmus Medical Centre, Rotterdam; Unit Transfusion Medicine, Sanquin Blood Supply Foundation, Amsterdam., Vermaat JSP; Department of Hematology, Leiden University Medical Centre, Leiden., de Weijer RJ; Department of Hematology, University Medical Centre Utrecht, Utrecht., Kersten MJ; Department of Hematology, Amsterdam UMC location University of Amsterdam, Cancer Centre Amsterdam and LYMMCARE, Amsterdam, The Netherlands., van Leeuwen FE; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam., Schaapveld M; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam. Electronic address: m.schaapveld@nki.nl.

المصدر: ESMO open [ESMO Open] 2024 Feb; Vol. 9 (2), pp. 102248. Date of Electronic Publication: 2024 Feb 12.

نوع المنشور: Multicenter Study; Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms, Second Primary*/epidemiology , Neoplasms, Second Primary*/etiology , Lymphoma, Large B-Cell, Diffuse*/epidemiology, Humans ; Rituximab/adverse effects ; Survivors ; Cyclophosphamide ; Doxorubicin

المؤلفون: Spoor DS; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, The Netherlands., Sijtsema NM; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, The Netherlands. Electronic address: n.m.sijtsema@umcg.nl., van den Bogaard VAB; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, The Netherlands., van der Schaaf A; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, The Netherlands., Brouwer CL; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, The Netherlands., Ta BDP; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, The Netherlands., Vliegenthart R; Department of Radiology, University of Groningen, University Medical Center Groningen, The Netherlands., Kierkels RGJ; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, The Netherlands., Langendijk JA; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, The Netherlands., Maduro JH; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, The Netherlands., Peters FBJ; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, The Netherlands., Crijns APG; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, The Netherlands.

المصدر: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2021 Oct; Vol. 163, pp. 46-54. Date of Electronic Publication: 2021 Jul 31.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8407192 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0887 (Electronic) Linking ISSN: 01678140 NLM ISO Abbreviation: Radiother Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms* , Breath Holding*, Female ; Heart/diagnostic imaging ; Heart Ventricles ; Humans ; Organs at Risk ; Radiotherapy Dosage ; Radiotherapy Planning, Computer-Assisted ; Respiration ; Tomography, X-Ray Computed